Ask Warren

Orientbio

002630 · KOSPI · ₩002630 · 오리엔트바이오

₩1,190▼ ₩39 (3.17%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩29B₩28B₩29B₩26B₩25B
Cost of sales₩22B₩18B₩19B₩17B₩19B
Gross profit₩7.2B₩9.6B₩9.8B₩9B₩6.2B
Operating income−₩3.1B−₩646M₩1.5B−₩3.8B−₩5.2B
Net income−₩13B₩13B−₩12B₩34B−₩20B
Net income to shareholders−₩13B₩13B−₩12B₩34B−₩20B

Balance sheet

20252024202320222021
Total assets₩85B₩97B₩81B₩105B₩62B
Current assets₩47B₩59B₩49B₩70B₩22B
Cash and equivalents₩6.5B₩6.1B₩5.9B₩30B₩4.6B
Total liabilities₩13B₩12B₩9.7B₩22B₩21B
Current liabilities₩4.2B₩4.2B₩3.9B₩14B₩13B
Borrowings₩105M₩105M₩1.4B₩6B₩6.5B
Total equity₩72B₩85B₩71B₩83B₩41B
Shareholders' equity₩72B₩85B₩71B₩83B₩41B

Cash flow

20252024202320222021
Cash from operations₩752M₩3.8B₩1.2B₩2.4B₩2.6B
Capital spending−₩4.8B₩891M₩470M₩2.2B₩212M
Free cash flow−₩4B₩2.9B₩689M₩145M₩2.3B

Consolidated where available. Amounts in won.

Also known as: Orientbio / 오리엔트바이오 / 002630 / KRX:002630

Source: KRX statistical information